Persistent parkinsonism following neuroleptanalgesia.
D000293:Adolescent; D000769:Anesthesia, Inhalation; D000771:Anesthesia, Intravenous; D004329:Droperidol / Q000009:adverse effects; D005260:Female; D005283:Fentanyl / Q000009:adverse effects; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D009458:Neuroleptanalgesia / Q000009:adverse effects*; D009609:Nitrous Oxide; D010300:Parkinson Disease / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D011433:Propranolol / Q000627:therapeutic use; D014081:Tooth Extraction; D014095:Tooth, Impacted / Q000601:surgery
D007980:Levodopa; D011433:Propranolol; D009609:Nitrous Oxide; D004329:Droperidol; D005283:Fentanyl